日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Impact of Infectious Disease Syndromes on Activities During Military Travel

传染病综合征对军事旅行活动的影响

Boatwright, Michael A; Kuo, Huai-Ching; Lindholm, David A; Griffith, Tara; Colombo, Rhonda E; Tribble, David R; O'Connell, Robert; Lalani, Tahaniyat

Amitriptyline Decreases GABAergic Transmission in Basal Forebrain Neurons Using an Optogenetic Model of Aging

利用光遗传学衰老模型研究发现,阿米替林可降低基底前脑神经元的GABA能传递。

Bang, Eunyoung; Tobery, Angelika; Montgomery, Karienn S; Fincher, Annette S; Earnest, David J; Murchison, David A; Griffith, William H

Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetes

降低代谢酮体还原率,发现用于治疗糖尿病的临床乙酰辅酶 A 羧化酶抑制剂

David A Griffith, Daniel W Kung, William P Esler, Paul A Amor, Scott W Bagley, Carine Beysen, Santos Carvajal-Gonzalez, Shawn D Doran, Chris Limberakis, Alan M Mathiowetz, Kirk McPherson, David A Price, Eric Ravussin, Gabriele E Sonnenberg, James A Southers, Laurel J Sweet, Scott M Turner, Felix F V

Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist

发现 1-[9-(4-氯苯基)-8-(2-氯苯基)-9H-嘌呤-6-基]-4-乙氨基哌啶-4-羧酸酰胺盐酸盐 (CP-945,598),一种新型、有效且选择性的大麻素 1 型受体拮抗剂

David A Griffith, John R Hadcock, Shawn C Black, Philip A Iredale, Philip A Carpino, Paul DaSilva-Jardine, Robert Day, Joseph DiBrino, Robert L Dow, Margaret S Landis, Rebecca E O'Connor, Dennis O Scott